IL22 and head and neck squamous cell carcinoma: After 72 hours of exogenous addition of IL22 recombinant protein in HNSCC cell lines, the killing ability at different E/T ratios after 6 hours of GFP+ T cells and CAR‐MUC1 T cells were detected.